In infants with ROP, increased incidence and severity of this illness may be due to subdued endogenous insulin signaling-induced liver insulin-like growth factor 1 (IGF1) reduction and use of IGF1 exerts significant inhibition on pathological neovascularization and improvement of physiologic retinal revascularization [77]. This evidence concerns the gene IGF1 and retinopathy of prematurity.